- HEATT market has potential applications for all solid metastatic cancers (estimated at 324k+ new cases in the US annually each with multiple treatment cycles)
- The market size of radiation is a $4.4B industry, growing at 5.3%/year
- Chemotherapy is estimated to reach $93B by 2016, growing at 8%/year.
- Overall US market for oncology will grow to $158B by 2020.
HEATT Total Market Opportunity is 900,000 procedures/year!
Strategic Advantages Over Other Technologies
- HEATT is a complement modality to:
- Abdominal cavity hyperthermia is well accepted, but has limited scope. Currently in 160 top medical centers.
- A few European firms have introduced non-effective, externally induced hyperthermia with no clinical data and ambiguous success due to poor therapeutic controls.
For more information about Verthermia, please submit the form below.